Spero Therapeutics (SPRO) Free Cash Flow (2017 - 2026)
Spero Therapeutics (SPRO) free cash flow from Jun 30, 2017 to Mar 31, 2026. The TTM Spero Therapeutics (SPRO) free cash flow is $7.24M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Spero Therapeutics (SPRO) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -1.78% |
Annual Free Cash Flow change of Spero Therapeutics (SPRO)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $16M | -225.67% |
| 2025 | -$13M | -46.16% |
| 2024 | -$23M | -28.95% |
| 2023 | -$33M | +326.78% |
| 2022 | -$7.73M | -87.99% |
| 2021 | -$64M | -25.20% |
| 2020 | -$86M | +70.93% |
| 2019 | -$50M | +19.66% |
| 2018 | -$42M | +165.20% |
| 2017 | -$16M | N/A |